About Sergio
I am an independent life science consultant and former Principal Investigator with 10+ years of experience across biotech and pharma, including roles at Almirall and Genmab, specializing in biologics, advanced antibody-based therapeutics, and gene therapy.
I support biotech and pharma teams with scientific and strategic input across discovery and early development, including target evaluation, program design, and progression toward clinical milestones.
My experience spans dermatology and immunology, with additional exposure to oncology. At Almirall, I led the discovery of a bispecific antibody program (anti‑IL‑13/OX40L) from concept to preclinical candidate nomination, and contributed to its transition toward IND-enabling development. I am a named inventor on this program and have authored peer-reviewed publications as first author.
Previously, I supported the translational development of Epcoritamab (EPKINLY®) at Genmab during late-stage clinical development, as well as early clinical proof-of-concept efforts for the HexaBody and DuoBody platforms.
I bring a pragmatic, execution-focused approach, with strong cross-functional collaboration across pharmacology, DMPK, CMC, and clinical teams, and a track record of advancing innovative programs toward clinical impact.
English
Native or bilingual
French
Conversational
Spanish
Native or bilingual
Catalan
Native or bilingual
Chinese
Basic
Can work on-site
Barcelona (up to 50km)
Experience
- Forward R&D ConsultingLife Science ConsultantRESEARCHApril 2026 - Today (2 months)Barcelona, SpainIndependent life sciences consultant and former Project Leader (Almirall, Genmab) with 10+ years’ experience across biotech and pharma. Focus on biologics, particularly bispecific antibodies, with additional experience in gene therapy. Background in dermatology, immunology, and immuno‑oncology. I support biotech and pharma teams with strategic input on early development, asset evaluation, and program design.
- AlmirallProgram Leader / PrincipalInvestigatorPHARMACEUTICALS INDUSTRYMarch 2021 - February 2026 (4 years and 11 months)Barcelona, Spain▪ Led a multidisciplinary Discovery Team to deliver the full Candidate Readiness Package for an anti‑IL‑13/OX40L bispecific antibody, enabling its transition into the Development phase (Preclinical Candidate Nomination) in 2023. Later, I served as Disease Biology representative collaborating on IND/enabling studies. The asset is now in the pipeline, and I am a listed inventor on the patent.▪ Generated innovative concepts for new targets and therapeutic approaches, leading small teams to develop Discovery Packages and, when needed, coordinating scientific collaborations with academic groups and industry partners.▪ Contributed to the assessment of external opportunities by supporting due‑diligence evaluations of small molecules, biologics, and gene‑therapy assets.
- Breast International Group (BIG)Scientific AdvisorMEDICALSeptember 2020 - February 2021 (5 months)Brussels, Belgium▪ Contributed to the development of translational research projects and patient-focused clinical trialresearch programs, including securing grant funding and coordinating the writing of manuscripts forpublication in scientific journals▪ Successfully obtained Certificate for the course “ICH-GCP: a guideline for good clinical practice (GCPElevate 2020/04)”
Recommendations
Be the first to recommend Sergio
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- PhDUniversity of Helsinki2012Adenovirus Vectors with Modified Tropism for the Treatment of Colorectal Cancer
- Master of Pharmacy (MPharm).University of Barcelona2005Master of Pharmacy (MPharm)